Biotech

News

Ottimo Pharma chief executive David Epstein

Ottimo raises $140m for its PD-1/VEGF cancer drug

Ottimo raises $140m for PD-1 and VEGF-targeting jankistomig, which the startup says is differentiated from bispecific antibodies in the class.

News

Novo Holdings leads $100m round for novel painkiller biotech

SiteOne Therapeutics has completed a $100 million third-round financing that will support clinical trials of its non-opioid painkiller.

News

Atlas closes $450m biotech fund, and other financing news

Atlas Venture raised $450m for its fourteenth biotech round, while Nuvig, Maze, and Antag also closed financings this week.

R&D

Partner Content

Biotech Showcase marking 17 years of innovation and opportun...

Biotech Showcase is a cornerstone of the life science industry, with a 17-year history of connecting private and micro- to mid-cap biotech companies with top-tier investors and biopharmaceu

News

Adcendo raises $135m for cancer ADCs, and other financings

Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma

News

Syncona aims Slingshot at biotech's 'translational gap'

UK-based life science investor Syncona has launched a new company – Slingshot Therapeutics – with a mission to find promising projects in academia and translate them into full-blown develop

Ottimo raises $140m for its PD-1/VEGF cancer drug

Novo Holdings leads $100m round for novel painkiller biotech

Atlas closes $450m biotech fund, and other financing news

Biotech Showcase marking 17 years of innovation and opportun...

Adcendo raises $135m for cancer ADCs, and other financings

Syncona aims Slingshot at biotech's 'translational gap'

Novo Nordisk gets FDA okay for Wegovy pill

How to meet your physicians where they are online

Biotech

Editor's Picks